Safety Study of CADI-05 in Patients With Advanced Stage Melanoma
This study has been terminated.
( DSMB reviewed data of 1st 10 subjects; determined no safety concerns. Efficacy as a single agent in this patient population was unlikely. Voluntary Termination )
Study NCT00675727
Information provided by Cadila Pharnmaceuticals
First Received on May 8, 2008.
Last Updated on June 10, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
